← Open Payments lookup

CATHERINE MCQUISTAN: Open Payments

NPI 1619419991 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$796 in 33 payments from 19 companies in 2025. Trend: 2023 $76 · 2024 $547 · 2025 $796

Food & beverage: $796
CompanyPaymentsAmount
ABBVIE INC.11$165
Regeneron Healthcare Solutions, Inc.2$140
Amgen Inc.1$120
Cleerly, Inc.1$42
Novo Nordisk Inc2$35
ANI Pharmaceuticals, Inc.2$35
Bayer Healthcare Pharmaceuticals Inc.2$32
Philips North America LLC1$29
Seqirus USA Inc1$29
Gilead Sciences, Inc.1$21

Products named: EVKEEZA, REPATHA, VRAYLAR, Cleerly Ischemia, QULIPTA, Wegovy, PURIFIED CORTROPHIN GEL, Kerendia.

Industry payments across NE — which companies pay providers there.